Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Whole Blood Coagulation Time | 3 | 2006 | 30 | 0.520 |
Why?
|
| Blood Coagulation Tests | 5 | 2005 | 263 | 0.500 |
Why?
|
| Hirudins | 2 | 2005 | 183 | 0.310 |
Why?
|
| Prothrombin Time | 3 | 2007 | 119 | 0.260 |
Why?
|
| Anticoagulants | 6 | 2006 | 4599 | 0.250 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2005 | 1066 | 0.240 |
Why?
|
| Monitoring, Ambulatory | 1 | 2000 | 358 | 0.140 |
Why?
|
| Peptide Fragments | 2 | 2005 | 5096 | 0.140 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 2288 | 0.140 |
Why?
|
| Warfarin | 1 | 2004 | 1497 | 0.130 |
Why?
|
| Heparin | 4 | 2004 | 1637 | 0.130 |
Why?
|
| Point-of-Care Systems | 7 | 2007 | 1177 | 0.130 |
Why?
|
| Protamines | 3 | 2004 | 106 | 0.130 |
Why?
|
| Heparin Antagonists | 2 | 2004 | 32 | 0.120 |
Why?
|
| Diltiazem | 1 | 1993 | 133 | 0.110 |
Why?
|
| Drug Therapy, Computer-Assisted | 2 | 2004 | 204 | 0.110 |
Why?
|
| Vitamin K | 2 | 2007 | 295 | 0.090 |
Why?
|
| Platelet Aggregation | 1 | 1993 | 798 | 0.090 |
Why?
|
| Blood Coagulation | 5 | 2005 | 1127 | 0.090 |
Why?
|
| Adenosine Triphosphate | 1 | 1993 | 2029 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2005 | 6620 | 0.070 |
Why?
|
| Computers, Handheld | 2 | 2004 | 208 | 0.060 |
Why?
|
| Food-Drug Interactions | 1 | 2004 | 27 | 0.060 |
Why?
|
| Enoxaparin | 1 | 2006 | 377 | 0.060 |
Why?
|
| International Normalized Ratio | 2 | 2007 | 367 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2004 | 3537 | 0.060 |
Why?
|
| Blood Platelets | 1 | 1993 | 2509 | 0.050 |
Why?
|
| Drug Monitoring | 2 | 2006 | 953 | 0.050 |
Why?
|
| Self Care | 1 | 2007 | 786 | 0.050 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2004 | 419 | 0.050 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2006 | 1874 | 0.050 |
Why?
|
| Aspirin | 1 | 1993 | 3283 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1993 | 3070 | 0.050 |
Why?
|
| Factor V | 1 | 2000 | 178 | 0.040 |
Why?
|
| Automation | 1 | 1999 | 584 | 0.040 |
Why?
|
| Reference Standards | 1 | 2000 | 1023 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2005 | 5078 | 0.030 |
Why?
|
| Phenobarbital | 1 | 1995 | 193 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2005 | 2159 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2002 | 1738 | 0.030 |
Why?
|
| Bleeding Time | 1 | 1993 | 89 | 0.030 |
Why?
|
| Factor VIII | 1 | 1996 | 347 | 0.030 |
Why?
|
| Platelet Activating Factor | 1 | 1993 | 149 | 0.030 |
Why?
|
| Hemostatics | 1 | 1995 | 229 | 0.030 |
Why?
|
| Thrombin Time | 2 | 2005 | 7 | 0.030 |
Why?
|
| Hemophilia A | 1 | 1996 | 351 | 0.030 |
Why?
|
| Adenosine Diphosphate | 1 | 1993 | 425 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 1993 | 434 | 0.030 |
Why?
|
| Equipment Design | 1 | 2000 | 3574 | 0.030 |
Why?
|
| Epinephrine | 1 | 1993 | 792 | 0.020 |
Why?
|
| Fetal Blood | 1 | 1995 | 1318 | 0.020 |
Why?
|
| Drug Synergism | 1 | 1993 | 1794 | 0.020 |
Why?
|
| Prenatal Care | 1 | 1995 | 1092 | 0.020 |
Why?
|
| Humans | 16 | 2007 | 743811 | 0.020 |
Why?
|
| Infant, Premature | 1 | 1995 | 2031 | 0.020 |
Why?
|
| Quality of Life | 1 | 2007 | 12788 | 0.020 |
Why?
|
| Hirudin Therapy | 1 | 2005 | 43 | 0.020 |
Why?
|
| Germany | 1 | 2007 | 862 | 0.020 |
Why?
|
| Partial Thromboplastin Time | 2 | 1996 | 206 | 0.020 |
Why?
|
| Research Design | 1 | 2000 | 5983 | 0.020 |
Why?
|
| Time Factors | 1 | 2005 | 40038 | 0.010 |
Why?
|
| Alabama | 1 | 2003 | 98 | 0.010 |
Why?
|
| Autoanalysis | 1 | 2002 | 72 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1999 | 19894 | 0.010 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2003 | 306 | 0.010 |
Why?
|
| Activated Protein C Resistance | 1 | 2000 | 21 | 0.010 |
Why?
|
| Software | 2 | 2004 | 4440 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 2007 | 57744 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2000 | 11708 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2007 | 2278 | 0.010 |
Why?
|
| Adult | 6 | 2007 | 213889 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1999 | 15281 | 0.010 |
Why?
|
| Biological Assay | 1 | 1999 | 650 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 2003 | 1073 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2007 | 3391 | 0.010 |
Why?
|
| Point Mutation | 1 | 2000 | 1623 | 0.010 |
Why?
|
| Heterozygote | 1 | 2000 | 2803 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 1999 | 14714 | 0.010 |
Why?
|
| Aged | 4 | 2007 | 163178 | 0.010 |
Why?
|
| Male | 5 | 2007 | 349776 | 0.010 |
Why?
|
| Algorithms | 2 | 2007 | 13869 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2002 | 2211 | 0.010 |
Why?
|
| Female | 5 | 2007 | 380020 | 0.010 |
Why?
|
| Middle Aged | 4 | 2007 | 213241 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2000 | 6170 | 0.010 |
Why?
|
| Observer Variation | 1 | 1996 | 2592 | 0.010 |
Why?
|
| Reference Values | 1 | 1995 | 4974 | 0.000 |
Why?
|
| Gestational Age | 1 | 1995 | 3488 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1995 | 12020 | 0.000 |
Why?
|
| Incidence | 1 | 2000 | 20948 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2000 | 40545 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1995 | 25609 | 0.000 |
Why?
|
| United States | 1 | 2002 | 69859 | 0.000 |
Why?
|
Concepts
(93)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_